Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 45, Issue 8, 2010, Pages 1363-1364

  Patel, A V ^a,b   Hahn, T ^a   Bogner, P N ^a   Loud, P A ^a   Brown, K ^a   Paplham, P ^a   Syta, M ^a   Battiwalla, M ^a   McCarthy, P L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DASATINIB; ETANERCEPT; FLUTICASONE; HEMOSIDERIN; HYDROXYCHLOROQUINE; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; SALMETEROL; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LUNG INJURY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIUM CULTURE; BRONCHOPNEUMONIA; CASE REPORT; CAUSE OF DEATH; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG FATALITY; DRUG FEVER; DRUG WITHDRAWAL; DYSPNEA; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPOXIA; KIDNEY FAILURE; LETTER; LUNG BIOPSY; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; LUNG TOXICITY; NEPHROTOXICITY; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; PUVA; RESPIRATORY FAILURE;

FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PULMONARY ALVEOLI; SIROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77955579177     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.339     Document Type: Letter

References (9)

1. Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 2003; 35(Suppl): 7S-14S.
2. Cutler C, Antin JH. Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 34: 471-476.
3. Majhail NS, Parks K, Defor TE, Weisdorf DJ. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant 2006; 12: 1038-1046.
4. Khalife WI, Kogoj P, Kar B. Sirolimus-induced alveolar hemorrhage. J Heart Lung Transplant 2007; 26: 652-657.
5. Lindenfeld JA, Simon SF, Zamora MR, Cool CD, Wolfel EE, Lowes BD et al. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. Am J Transplant 2005; 5: 1392-1396.
6. Champion L, Stern M, Israel-Biet D, Mamzer-Bruneel MF, Peraldi MN, Kreis H et al. Brief communication: sirolimus- associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med 2006; 144: 505-509.
7. Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant 2005; 19: 698-703.
8. Morelon E, Stern M, Israel-Biet D, Correas JM, Danel C, Mamzer-Bruneel MF et al. Characteristics of sirolimus- associated interstitial pneumonitis in renal transplant patients. Transplantation 2001; 72: 787-790.
9. Vlahakis NE, Rickman OB, Morgenthaler T. Sirolimus- associated diffuse alveolar hemorrhage. Mayo Clin Proc 2004; 79: 541-545.